Theoretical and experimental relationships between percent inhibition and IC50 data observed in high-throughput

Hanspeter Gubler1, Ulrich Schopfer, Edgar Jacoby

  • 1Informatics and Technology, Novartis Pharma AG, Institutes for BioMedical Research, Basel, Switzerland. hanspeter.gubler@novartis.com